靶向类固醇经硬膜外导管注射与标准经椎间孔注射治疗单侧颈神经根性疼痛的1年随机对照试验结果
这项前瞻性随机对照试验比较了经硬膜外导管注射曲安奈德与经椎间孔注射地塞米松治疗难治性单侧颈神经根性疼痛的1年疗效。分析117例受试者,1年时导管组61.2%与经椎间孔组51.9%达到主导疼痛≥50%缓解(p=0.35),两组在颈部功能障碍指数和总体印象改善方面亦无显著差异。结论认为两种方法在1年内对多数患者均有效。
要点
- 1年时两组主导疼痛≥50%缓解率无显著差异(61.2% vs 51.9%,p=0.35)。
- 颈部功能障碍指数≥30%改善率两组分别为60.4%和47.1%(p=0.18)。
- 患者总体印象改善两组相似(60.5% vs 57.5%,p=0.79)。
核心结论
- 经硬膜外导管颈段 interlaminar 注射曲安奈德与经椎间孔注射地塞米松均能在1年内有效减轻多数难治性单侧颈神经根病患者的疼痛和功能障碍。
研究设计与样本
- 前瞻性、随机、对照试验,分析117例受试者(55.6%女性;年龄52.3±12.5岁;BMI 28.2±6.5 kg/m²)。
主要发现
- 1年时导管组61.2%(95%CI 46.9%至73.9%)与经椎间孔组51.9%(95%CI 38.4%至65.2%)报告主导疼痛≥50%缓解(p=0.35)。
- 颈部功能障碍指数≥30%改善率导管组60.4%(95%CI 45.9%至73.3%),经椎间孔组47.1%(95%CI 33.7%至60.8%)(p=0.18)。
- 患者总体印象改善为「明显改善」或「非常明显改善」的比例导管组60.5%(95%CI 44.2%至74.8%),经椎间孔组57.5%(95%CI 41.7%至71.9%)(p=0.79)。
关键数值与推荐
- 主要结局指标为主导疼痛(手臂或颈部疼痛中较重者)数字评定量表较基线降低≥50%的受试者比例。
- 次要结局包括颈部功能障碍指数降低≥30%和患者总体印象改善达到「明显改善」或「非常明显改善」。
临床怎么用
- 对于难治性单侧颈神经根性疼痛,两种靶向类固醇注射方式均可考虑,1年疗效无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of this study was to evaluate the long-term effectiveness of catheter-directed cervical interlaminar epidural steroid injection with triamcinolone compared with cervical transforaminal steroid injection with dexamethasone for the treatment of refractory unilateral radicular pain. DESIGN: Prospective, randomized, comparative trial. METHODS: The primary outcome was the proportion of participants with ≥50% Numeric Rating Scale 'dominant pain' (the greater of arm vs neck) reduction from baseline. Secondary outcomes included ≥30% Neck Disability Index reduction and Patient Global Impression of Change response indicating 'much improved' or 'very much improved'. RESULTS: Data from 117 participants (55.6% women; 52.3±12.5 years of age; body mass index, 28.2±6.5 kg/m2) were analyzed. The proportion of participants who experienced ≥50% pain reduction at 1 month, 3 months, and 6 months has been previously reported. At 1 year, 61.2% (95% CI, 46.9% to 73.9%) of the catheter group compared with 51.9% (95% CI, 38.4% to 65.2%) of the transforaminal group reported ≥50% 'dominant' pain reduction (p=0.35). The proportion of participants who experienced ≥30% improvement in Neck Disability Index score was 60.4% (95% CI, 45.9% to 73.3%) and 47.1% (95% CI, 33.7% to 60.8%) in the catheter and transforaminal groups (p=0.18). Patient Global Impression of Change improvement was similar in both groups: 60.5% (95% CI, 44.2% to 74.8%) and 57.5% (95% CI, 41.7% to 71.9%) of the catheter and transforaminal groups reported being 'much improved' or 'very much improved', respectively (p=0.79). CONCLUSION: Both cervical catheter-directed interlaminar epidural injection and cervical transforaminal steroid injection were effective in reducing pain and disability in the majority of participants with refractory unilateral cervical radiculopathy for up to 1 year.
引用
- Conger A, Kendall RW, Sperry BP, et al. One-year results from a randomized comparative trial of targeted steroid injection via epidural catheter versus standard transforaminal epidural injection for the treatment of unilateral cervical radicular pain. Reg Anesth Pain Med. 2021. PMID: 33990435. doi:10.1136/rapm-2021-102514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。